See every side of every news story

Published 2 days ago • loading... • Updated 2 days ago

New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting

Summary by Helena Independent Record

Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo in patients who had atopic dermatitis and a history of asthma

36 Articles

36 Articles

Helena Independent Record

+35 Reposted by 35 other sources

New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting

Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo in patients who had atopic dermatitis and a history of asthma

2 days ago·Helena, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources36

Leaning Left2Leaning Right1Center11Last Updated19 hours agoBias Distribution

79% Center

Bias Distribution

79% of the sources are Center

79% Center

+6

Untracked bias

+13

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Helena Independent Record broke the news in Helena, United States 2 days ago on Saturday, November 8, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics